What's the difference between Semaglutide and Tirzepatide?+ Semaglutide targets one receptor (GLP-1), while Tirzepatide targets two (GLP-1 and GIP)
We did not observe any significant group differences in brain GSH or circulating concentrations of peripheral blood markers
For enhanced weight loss results, Zepbound combines GIP and GLP-1 agonists
There were also noted improvements in markers of glycemic control and insulin sensitivity
Conclusion This study provides insights into psychometric properties of PROMIS Pediatric measures in the Dutch pediatric oncology population, supporting their implementation and improving patient-centered outcome assessments
Kenneth McCall, published a paper in 2025 finding that compounded GLP-1s were linked to higher rates of adverse effects than non-compounded products between 2018 and 2024, including more abdominal pain, diarrhea, and nausea